Moreover, HER2 + BC patients with higher HSP90AA1 values demonstrated a significantly unfavorable OS than patients with lower values (HR = 2.37; 95%CI = 1.27–4.45; p-value 0.006) (Figure 7). This evidence concerns the gene HSP90AA1 and breast cancer.